Lind Global Fund II SC 13G Vallon Pharmaceuticals / Lind Global Fund II ownership change

Exhibit 99.2

Due to the relationships amongst them, all of the Reporting Persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended.